| | | | | | | | | | |
|
|
| Dockets Entered On
March 15, 2004
Table of Contents
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
| 1978N-0064
|
| OTC Antiperspirant
|
|
|
| 1991N-0098
|
| Dietary Fiber & Cancer, Health Claims & Label Statements
|
|
|
| 1991N-0100H
|
| Health Claims & Label Statements; Folate & Neural Tube Defec
|
|
|
| 1991N-0101
|
| Antioxidant Vitamins & Cancer,Hlth. Claims & Label Statement
|
|
|
| 1991N-0103
|
| Fatty Acids & Heart Disease, Hlth.Claims & Label Statements
|
|
|
| 1992N-0489
|
| Taxol; Enviromental Assessments and Fonsi
|
|
|
| 1993N-0480A
|
| Health Claims for Antioxidant Vitamins & Cancer
|
|
|
| 1993N-0480C
|
| Health Claims for Dietary Fiber & CVD
|
|
|
| 1993N-0480F
|
| Health Claims for Dietary Fiber & Cancer
|
|
|
| 1995N-0304
|
| Ephedrine Alkaloids: Reports of Adverse Events; Availability
|
|
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
|
|
| 1999N-4282
|
| Biotechnology in the Year 2000 and Beyond; Public Meetings
|
|
|
| 1999P-2630
|
| Establish a Daily Value for "added sugars"
|
|
|
| 2000P-1322
|
| Food Labeling and Allergen Contamination Control
|
|
|
| 2001P-0075
|
| Switch Status of Emergency Contraceptives from Rx to OTC
|
|
|
| 2002N-0204
|
| Bar Code Label Requirements for human drug products
|
|
|
| 2002N-0417
|
| Applications for FDA Approval to Market a New Drug
|
|
|
| 2003D-0493
|
| Guidance on Powder Blends and Finished Dosage Units -- Stratified In-Process Dosage Unit Sampling and Assessmen
|
|
|
| 2003N-0076
|
| Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
|
|
|
| 2003N-0496
|
| Food Labeling: Health Claims; Dietary Guidance
|
|
|
| 1978N-0064
|
| OTC Antiperspirant
|
|
|
| SUP
5
|
| Revlon, Inc.
|
| Vol #:
|
| 51
|
|
|
| 1991N-0098
|
| Dietary Fiber & Cancer, Health Claims & Label Statements
|
|
|
| MT
1
|
| HFS-832 to Emord & Associates, PC
|
| Vol #:
|
| 1
|
|
|
| 1991N-0100H
|
| Health Claims & Label Statements; Folate & Neural Tube Defec
|
|
|
| MT
1
|
| HFS-832 to Emord & Associates, PC
|
| Vol #:
|
| 16
|
|
|
| 1991N-0101
|
| Antioxidant Vitamins & Cancer,Hlth. Claims & Label Statement
|
|
|
| MT
1
|
| HFS-832 to Emord & Associates, PC
|
| Vol #:
|
| 46
|
|
|
| 1991N-0103
|
| Fatty Acids & Heart Disease, Hlth.Claims & Label Statements
|
|
|
| MT
1
|
| HFS-832 to Emord & Associates, PC
|
| Vol #:
|
| 58
|
|
|
| 1992N-0489
|
| Taxol; Enviromental Assessments and Fonsi
|
|
|
| EA
5
|
| TAXUS Express Paclitaxel-Eluting Coronary Stent System
|
| Vol #:
|
| 16
|
|
| | | | | | | | |
|
|
| 1993N-0480A
|
| Health Claims for Antioxidant Vitamins & Cancer
|
|
|
| MT
1
|
| HFS-832 to Emord & Associates, PC
|
| Vol #:
|
| 1
|
|
|
| 1993N-0480C
|
| Health Claims for Dietary Fiber & CVD
|
|
|
| MT
1
|
| HFS-832 to Emord & Associates, PC
|
| Vol #:
|
| 1
|
|
|
| 1993N-0480F
|
| Health Claims for Dietary Fiber & Cancer
|
|
|
| MT
1
|
| HFS-832 to Emord & Associates, PC
|
| Vol #:
|
| 1
|
|
|
| 1995N-0304
|
| Ephedrine Alkaloids: Reports of Adverse Events; Availability
|
|
|
| EMC 1272
|
| No signature
|
| Vol #:
|
| 378
|
|
|
| EMC 1273
|
| D. Monnier
|
| Vol #:
|
| 378
|
|
|
| EMC 1274
|
| No signature
|
| Vol #:
|
| 378
|
|
|
| EMC 1275
|
| K. Quillen
|
| Vol #:
|
| 378
|
|
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
|
|
| LET
13230
|
| Enzymatic Therapy Natural Medicines
|
| Vol #:
|
| 108
|
|
|
| LET
13231
|
| Pharmavite LLC
|
| Vol #:
|
| 108
|
|
|
| LET
13232
|
| PhytoPharmica Natural Medicines
|
| Vol #:
|
| 108
|
|
|
| LET
13233
|
| Enzymatic Therapy Natural Medicines
|
| Vol #:
|
| 108
|
|
|
| LET
13234
|
| Tronex Pharmaceuticals Industries
|
| Vol #:
|
| 108
|
|
|
| LET
13235
|
| Perrigo Company of South Carolina
|
| Vol #:
|
| 108
|
|
|
| LET
13236
|
| LifeSpan Nutrition
|
| Vol #:
|
| 108
|
|
|
| LET
13237
|
| VitalState Inc.
|
| Vol #:
|
| 108
|
|
|
| LET
13238
|
| Health Direct (HD Nutrition, Inc.)
|
| Vol #:
|
| 108
|
|
|
| LET
13239
|
| Body Wise International, Inc.
|
| Vol #:
|
| 108
|
|
|
| LET
13240
|
| Body Wise International, Inc.
|
| Vol #:
|
| 108
|
|
|
| LET
13241
|
| Body Wise International, inc.
|
| Vol #:
|
| 108
|
|
|
| LET
13242
|
| Body Wise International, Inc.
|
| Vol #:
|
| 108
|
|
|
| LET
13243
|
| Body Wise International, Inc.
|
| Vol #:
|
| 108
|
|
|
| LET
13244
|
| Enzynmatic Therapy Natural Medicines
|
| Vol #:
|
| 108
|
|
|
| LET
13245
|
| Enzymatic Therapy Natural Medicines
|
| Vol #:
|
| 108
|
|
|
| LET
13246
|
| Enzymatic Therapy Natural Medicines
|
| Vol #:
|
| 108
|
|
|
| LET
13247
|
| Enzymatic Therapy Natural Medicines
|
| Vol #:
|
| 108
|
|
|
| LET
13248
|
| Enzymatic Therapy Nautral Medicines
|
| Vol #:
|
| 108
|
|
|
| LET
13249
|
| Enzymatic Therapy Natural Medicines
|
| Vol #:
|
| 109
|
|
|
| LET
13250
|
| Enzymatic Therapy Natural Medicines
|
| Vol #:
|
| 108
|
|
|
| LET
13251
|
| Enzymatic Therapy Natural Medicines
|
| Vol #:
|
| 109
|
|